Type 2 diabetic mice with NASH showed significant changes in plasma levels of adipocytokines, increases in leptin and FGF‐21, and decreases in adiponectin (Figure 6). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.